Effect of Ranibizumab on High-Speed Indocyanine Green Angiography and Minimum Intensity Projection Optical Coherence Tomography Findings in Neovascular Age-Related Macular Degeneration. Retina, 35, 58-68. presented at the 01/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25077529. (2015).
A Randomized 36-Week Crossover Trial Comparing Ranibizumab and Bevacizumab for Diabetic Macular Edema. In 2015 Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO). presented at the 03/05/2015, Denver, CO. Retrieved from http://www.arvo.org/Annual_Meeting/Past_Annual_Meetings/. (2015).
Circularity Index as a Risk Factor for Progression of Geographic Atrophy. Ophthalmology, 120, 2666-2671. presented at the 12/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24206616. (2013).
Treatment of Geographic Atrophy by the Topical Administration of OT-551: Results of a Phase II Clinical Trial. Invest Ophthlmol Vis Sci, 51, 613-619. presented at the 12/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20574018. (2010).
Effects of Multivitamin/Mineral Supplementation on Plasma Levels of Nutrients. Report No. 4 of the Italian-American Clinical Trial of Nutritional Supplements and Age-Related Cataract. Ann Ist Super Sanita, 45, 119-127. presented at the 04/2009. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19636163. (2009).
A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Multivitamin Supplementation for Age-Related Lens Opacities. Clinical Trial of Nutritional Supplements and Age-Related Cataract Report No. 3. Ophthalmology, 115, 599-607 e1. presented at the 04/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18387406. (2008).
Intravitreal Anti-Vascular Endothelial Growth Factor Therapy with Pegaptanib for Advanced Von Hippel-Lindau Disease of the Retina. Retina, 27, 150-158. presented at the 02/2007. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17290195. (2007).
Visual Acuity as an Outcome Measure in Clinical Trials of Retinal Diseases. Ophthalmology, 114, 1804-1809. presented at the 10/2007. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17908590. (2007).
Dose Ranging Study of Lutein Supplementation in Persons Aged 60 Years or Older. Invest Ophthalmol Vis Sci, 47, 5227-5233. presented at the 12/2006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17122107. (2006).
The Effect of Lutein and Zeaxanthin Supplementation on Metabolites of These Carotenoids in the Serum of Persons Aged 60 or Older. Invest Ophthalmol Vis Sci, 47, 5234-5242. presented at the 12/2006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17122108. (2006).
A Simplified Severity Scale for Age-Related Macular Degeneration. AREDS Report No. 18. Arch Ophthalmol, 123, 1570-1574. presented at the 11/2005. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16286620. (2005).
The Long-Term Effects of Laser Photocoagulation Treatment in Patients with Diabetic Retinopathy: The Early Treatment Diabetic Retinopathy Follow-up Study. Ophthalmology, 110, 1683-89. presented at the 2003.. (2003).